MIBG (Metaiodobenzylguanidine) therapy is a type of radioactive iodine treatment used to diagnose and treat certain types of pheochromocytoma and paraganglioma, which are tumors that produce excessive amounts of catecholamines. The therapy involves injecting the patient with MIBG, which is then absorbed by these tumors, allowing them to be located and detected through radioimaging or scanning. Additionally, for therapeutic purposes, a small dose of radioactive iodine-131 is often given along with MIBG to destroy the tumor cells.
MIBG (Metaiodobenzylguanidine) therapy is a type of radioactive iodine treatment used to diagnose and treat certain types of pheochromocytoma and paraganglioma, which are tumors that produce excessive amounts of catecholamines. The therapy involves injecting the patient with MIBG, which is then absorbed by these tumors, allowing them to be located and detected through radioimaging or scanning. Additionally, for therapeutic purposes, a small dose of radioactive iodine-131 is often given along with MIBG to destroy the tumor cells.